Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Lowered to $13 at Goldman Sachs

November 6, 2017 5:28 AM
Goldman Sachs lowered its price target on Teva Pharma (NYSE: TEVA) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles